KINIKSA PHARMACEUTICALS INTL

Ticker: KNSA CUSIP: G52694109 Class: Common Stock

Fairmount Funds Management LLC's Holding History (CIK: 0001802528)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 1,319,688 Value ($000) $54,437 Avg Close $40.11 Range $35.20 - $44.42

Q3 2025

Shares 1,772,839 Value ($000) $68,839 Avg Close $32.49 Range $26.27 - $39.00

Q2 2025

Shares 1,772,839 Value ($000) $49,054 Avg Close $25.46 Range $18.25 - $30.69

Q1 2025

Shares 1,102,248 Value ($000) $24,481 Avg Close $20.58 Range $17.82 - $24.31

Q4 2024

Shares 2,194,341 Value ($000) $43,404 Avg Close $22.82 Range $19.47 - $28.15

Q3 2024

Shares 3,204,841 Value ($000) $80,089 Avg Close $24.36 Range $17.38 - $27.92

Q2 2024

Shares 3,204,841 Value ($000) $59,834 Avg Close $18.73 Range $16.56 - $20.52

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	1,319,688	$54,437	$40.11	$35.20 - $44.42
Q3 2025	1,772,839	$68,839	$32.49	$26.27 - $39.00
Q2 2025	1,772,839	$49,054	$25.46	$18.25 - $30.69
Q1 2025	1,102,248	$24,481	$20.58	$17.82 - $24.31
Q4 2024	2,194,341	$43,404	$22.82	$19.47 - $28.15
Q3 2024	3,204,841	$80,089	$24.36	$17.38 - $27.92
Q2 2024	3,204,841	$59,834	$18.73	$16.56 - $20.52